(3R)-1-Oxo-3-methyl-8-hydroxy-3,4-dihydro-1H-2-benzopyran-5-carbaldehyde

Details

Top
Internal ID 1f8e35d0-b2a7-400a-8a46-9245901bc136
Taxonomy Organoheterocyclic compounds > Benzopyrans > 2-benzopyrans
IUPAC Name (3R)-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-5-carbaldehyde
SMILES (Canonical) CC1CC2=C(C=CC(=C2C(=O)O1)O)C=O
SMILES (Isomeric) C[C@@H]1CC2=C(C=CC(=C2C(=O)O1)O)C=O
InChI InChI=1S/C11H10O4/c1-6-4-8-7(5-12)2-3-9(13)10(8)11(14)15-6/h2-3,5-6,13H,4H2,1H3/t6-/m1/s1
InChI Key PTNGWSBREHHWFF-ZCFIWIBFSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C11H10O4
Molecular Weight 206.19 g/mol
Exact Mass 206.05790880 g/mol
Topological Polar Surface Area (TPSA) 63.60 Ų
XlogP 1.90
Atomic LogP (AlogP) 1.31
H-Bond Acceptor 4
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
(3R)-1-Oxo-3-methyl-8-hydroxy-3,4-dihydro-1H-2-benzopyran-5-carbaldehyde

2D Structure

Top
2D Structure of (3R)-1-Oxo-3-methyl-8-hydroxy-3,4-dihydro-1H-2-benzopyran-5-carbaldehyde

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9636 96.36%
Caco-2 + 0.6151 61.51%
Blood Brain Barrier - 0.8500 85.00%
Human oral bioavailability - 0.5571 55.71%
Subcellular localzation Mitochondria 0.6883 68.83%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8557 85.57%
OATP1B3 inhibitior + 0.9906 99.06%
MATE1 inhibitior - 0.8400 84.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.9242 92.42%
P-glycoprotein inhibitior - 0.9694 96.94%
P-glycoprotein substrate - 0.9150 91.50%
CYP3A4 substrate - 0.5594 55.94%
CYP2C9 substrate + 0.6383 63.83%
CYP2D6 substrate - 0.8476 84.76%
CYP3A4 inhibition - 0.8515 85.15%
CYP2C9 inhibition + 0.5973 59.73%
CYP2C19 inhibition - 0.9001 90.01%
CYP2D6 inhibition - 0.9036 90.36%
CYP1A2 inhibition + 0.5679 56.79%
CYP2C8 inhibition - 0.9067 90.67%
CYP inhibitory promiscuity - 0.9415 94.15%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.9413 94.13%
Carcinogenicity (trinary) Non-required 0.5510 55.10%
Eye corrosion - 0.9670 96.70%
Eye irritation + 0.9737 97.37%
Skin irritation - 0.5401 54.01%
Skin corrosion - 0.9121 91.21%
Ames mutagenesis + 0.5400 54.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7972 79.72%
Micronuclear + 0.7059 70.59%
Hepatotoxicity + 0.7566 75.66%
skin sensitisation - 0.8672 86.72%
Respiratory toxicity + 0.6889 68.89%
Reproductive toxicity + 0.8444 84.44%
Mitochondrial toxicity + 0.8000 80.00%
Nephrotoxicity + 0.6874 68.74%
Acute Oral Toxicity (c) I 0.5455 54.55%
Estrogen receptor binding + 0.6815 68.15%
Androgen receptor binding + 0.5435 54.35%
Thyroid receptor binding - 0.6722 67.22%
Glucocorticoid receptor binding - 0.6350 63.50%
Aromatase binding - 0.8792 87.92%
PPAR gamma - 0.6114 61.14%
Honey bee toxicity - 0.9383 93.83%
Biodegradation - 0.5000 50.00%
Crustacea aquatic toxicity - 0.5800 58.00%
Fish aquatic toxicity + 0.8894 88.94%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL1951 P21397 Monoamine oxidase A 99.35% 91.49%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 97.80% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 97.53% 95.56%
CHEMBL1163101 O75460 Serine/threonine-protein kinase/endoribonuclease IRE1 95.92% 98.11%
CHEMBL2581 P07339 Cathepsin D 92.75% 98.95%
CHEMBL1806 P11388 DNA topoisomerase II alpha 89.24% 89.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 86.58% 86.33%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 85.78% 99.23%
CHEMBL4208 P20618 Proteasome component C5 84.22% 90.00%
CHEMBL3401 O75469 Pregnane X receptor 83.73% 94.73%
CHEMBL2553 Q15418 Ribosomal protein S6 kinase alpha 1 80.27% 85.11%

Cross-Links

Top
PubChem 44577733
NPASS NPC130833
LOTUS LTS0096213
wikiData Q105214772